1 Lemieux B, "Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma" 33 : 921-923, 2004
2 Saikia TK, "Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin’s lymphoma and corrected with IVIG" 12 : 1493-1494, 2001
3 Voog E, "Neutropenia in patients treated with rituximab" 348 : 2691-2694, 2003
4 Terrier B, "Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced Bcell recovery" 92 : e20-e23, 2007
5 Lai GG, "Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma" 84 : 414-417, 2009
6 Tesfa D, "Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis" 25 : 374-379, 2008
7 Hirayama Y, "Late onset neutropenia and immunoglobulin suppression of the patients with malignant lymphoma following autologous stem cell transplantation with rituximab" 48 : 57-60, 2009
8 Papadaki T, "Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases" 26 : 597-600, 2002
9 Chaiwatanatorn K, "Delayedonset neutropenia associated with rituximab therapy" 121 : 913-918, 2003
10 Cattaneo C, "Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments" 47 : 1013-1017, 2006
1 Lemieux B, "Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma" 33 : 921-923, 2004
2 Saikia TK, "Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin’s lymphoma and corrected with IVIG" 12 : 1493-1494, 2001
3 Voog E, "Neutropenia in patients treated with rituximab" 348 : 2691-2694, 2003
4 Terrier B, "Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced Bcell recovery" 92 : e20-e23, 2007
5 Lai GG, "Late-onset neutropenia following RCHOP chemotherapy in diffuse large B-cell lymphoma" 84 : 414-417, 2009
6 Tesfa D, "Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis" 25 : 374-379, 2008
7 Hirayama Y, "Late onset neutropenia and immunoglobulin suppression of the patients with malignant lymphoma following autologous stem cell transplantation with rituximab" 48 : 57-60, 2009
8 Papadaki T, "Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases" 26 : 597-600, 2002
9 Chaiwatanatorn K, "Delayedonset neutropenia associated with rituximab therapy" 121 : 913-918, 2003
10 Cattaneo C, "Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments" 47 : 1013-1017, 2006
11 Dunleavy K, "B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis" 106 : 795-802, 2005
12 Nitta E, "A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma:a single-institution study" 18 : 364-369, 2007